Notice
Products
Resources
Log inSign up
  • Trading
  • Monitoring
  • Research
  • Notice Pro
  • Why Notice
  • Screener
  • Notice 50
  • nav.rankings
  • nav.ipoCalendar
  • Trends
  • About
  • Help center
Beta Bionics Stock

Beta Bionics Stock

Last updated on May 12, 2025
4.18
-0.02
(-0.43%)
Past consensus
6.69Retail max
OverviewMarketValuationRevenueFundingInvestors

Beta Bionics Stock Price Chart

Beta Bionics stock price is built algorithmically using secondary market and reference data. Learn more Disclosures

How to buy Beta Bionics

The world's most experienced Beta Bionics brokers are here to advise you on buying and selling opportunities.

About Beta Bionics, Inc.

Beta Bionics pioneers transformative medical devices for diabetes care seekers, spearheading the charge with their iLet Bionic Pancreas. This advanced system, capable of bihormonal regulation, is a beacon of promise for those seeking to manage diabetes with greater ease. As a public benefit Certified B Corporation, Beta Bionics stands apart as a symbol of commitment to the global diabetes community. Their focus spans from the conceptual to the commercial, with unwavering dedication to innovation and service. Technical prowess, married with a people-centric ethos, propels Beta Bionics toward their singular goal — the betterment of diabetic care.

Founded
2015
Employees
301
Website
betabionics.com
Last round
-
Market Cap
$307.00 M1
Premium
-
Total Funding
Days Since Funding
1772
Coverage Ratio
-
Health & Wellness
Electronics
Medical Devices
1
Last round valuation used because market cap cannot be calculated

Beta Bionics Market

Transferability unknown
We do not know if Beta Bionics allows direct stock transfers. if you know the current transfer rules for Beta Bionics.
Beta Bionics has low market activity. There are no buyers or sellers of Beta Bionics at this time. It can take time for markets to develop around private companies. Buyer demand typically drives markets in private companies. Here are the major factors:
  • News: Positive company developments that garner extensive news coverage including large funding rounds or product launches can generate investor demand.
  • Size: Investor demand also tends to be correlated with company valuation where the larger companies attract more secondary market investor attention.
  • Sector: Hot sectors like AI can create halo effects that drive investor demand more broadly into the sector as a whole.
  • Age: Finally, older companies typically have more sellers as employees have vested and investors are pushed to liquidate positions to generate returns.
So, older large companies with continuous positive news cycles in hot sectors tend to be the most liquid. SpaceX is a good example of a highly liquid name.
or sign up and post an indication of interest to explore opportunities to transact Beta Bionics.

Beta Bionics Stock Price

Trailing performance

1 Day
-
1 Week
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
2 Years
-
5 Years
-
All Time
-

Quarterly performance

Beta Bionics stock is not currently traded in the private markets. We do not have enough data to print a price history for Beta Bionics right now. If you can share any Beta Bionics stock trade data or funding round price per share, then we can start pricing coverage for Beta Bionics.

Beta Bionics Valuation

We are missing all Beta Bionics funding round valuations. Sometimes these details are not shared in funding announcements or corporate filings. If you can share valuations for any funding rounds that Beta Bionics has done, then we can start valuation coverage for Beta Bionics.

Frequently Asked Questions

Does Beta Bionics have stock?

Yes. Beta Bionics is a private venture-backed company. Investors usually purchase preferred stock and employees typically receive common stock options or restricted stock units (RSUs) as part of their compensation.

What is Beta Bionics's stock symbol?

Since it is not publicly listed, there is no Beta Bionics stock symbol or Beta Bionics ticker symbol assigned for Beta Bionics.

Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Security Exchange Commission when they start the IPO process.

How can I sell Beta Bionics stock?

If you own shares of a private company, it may be possible to find liquidity for your holdings before the company goes public. Finding the right private market broker can make all the difference as the best brokers can leverage deep industry relationships and negotiate on your behalf.

If you are interested in selling private stock you can reach out to Premier brokers for more information.

How do Beta Bionics pre-IPO trades work?

Private market transactions can be complex and may involve company approvals, legal purchase agreements and wires to third parties. Trades can take 30 - 60 days to complete which is why many investors work with experienced private market brokers to help guide the process.

Direct share transfers typically require issuer approvals. Issuers may exercise the right of first refusal (ROFR) in order to direct the seller to a buyer of their choosing.

Some issuers do not allow transactions. In these cases, buyers will need to purchase indirect interests in the business via special purpose vehicles (SPVs) or forward purchase contracts (forwards).

Is Beta Bionics publicly traded?

Beta Bionics stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Beta Bionics stock might be available for purchase in the secondary markets, but Beta Bionics stock is not available for purchase by the general public, and can not be purchased through traditional brokerage accounts.

How can I buy Beta Bionics stock?

Only accredited investors and qualified purchasers can buy private stock. These investors buy pre-IPO stock in the secondary market from existing employees and investors.

To learn more about the market for Beta Bionics stock, talk to the best brokers on the planet.

How to invest in Beta Bionics?

Accredited investors can purchase shares in private companies like Beta Bionics. Investors can rely on Notice Premier Brokers to find supply and guide them through the trading process.

Because Beta Bionics is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. Retail investors can not access this stock via traditional brokerage accounts, and are not allowed to invest directly in Beta Bionics pre-IPO.

How is Notice pricing Beta Bionics?

Notice Price is algorithmically generated based on a number of inputs like private market activity, official company filings, internal marks, and comparables.

Developing accurate pricing for the private market, and making that pricing available to everyone has always been our mission.

  1. Notice
  2. /
  3. Companies
  4. /
  5. Health & Wellness
  6. /
  7. Electronics

Popular companies

©2025 Notice, Inc.TermsPrivacyDisclaimersLearn
LinkedInTwitterFacebookMedium
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON NOTICE.CO ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT. NOTICE, INC., TOGETHER WITH ITS AFFILIATES ("NOTICE") IS NOT A BROKER-DEALER, INVESTMENT ADVISER OR ANY OTHER TYPE OF FINANCIAL PROFESSIONAL. NO PLATFORM CONTENT SHOULD BE CONSIDERED AN OFFER, SOLICITATION OF AN OFFER, OR ADVICE TO BUY OR SELL SECURITIES OR ANY OTHER TYPE OF INVESTMENT OR FINANCIAL PRODUCT. BY USING THE PLATFORM YOU UNDERSTAND AND AGREE THAT NOTICE DOES NOT PROVIDE INVESTMENT ADVICE; RECOMMEND ANY SECURITY, TRANSACTION OR ORDER; FACILITATE BROKERAGE REFERRALS; OR PROVIDE ANY OTHER TYPE OF FINANCIAL PRODUCT OR SERVICE. YOU MAY NOT DIRECTLY PURCHASE SHARES OF PRIVATE COMPANIES ON THE PLATFORM. PRIVATE OFFERINGS AVAILABLE THROUGH THE PLATFORM INVOLVE THE OFFER AND SALE OF MEMBERSHIP INTERESTS IN LIMITED LIABILITY COMPANIES THAT MAY HOLD SHARES OF PRIVATE COMPANIES. ANY REFERENCES ON THE PLATFORM TO 'SHARES', 'PRICE PER SHARE', 'STOCK' OR OTHER SIMILAR TERMINOLOGY ARE FOR ADMINISTRATIVE CONVENIENCE ONLY. The content on the Notice website ("Platform") produced by Notice, in part, (the "Platform Content"), is based on aggregated data from the voluntary disclosure by certain of Notice's Users and/or publicly available information. Notice does not have an obligation to update Platform Content and none of the information provided by Notice constitutes investment, tax, or legal advice. All information provided by Notice is for informational purposes only. Platform Content is not an endorsement of and does not suggest any affiliation to any third parties related to the Platform Content. Notice makes no representations or warranties with respect to the Platform Content and will not be liable for Platform Content or any action (or inaction) taken in reliance on such Platform Content. Notice does not guarantee or makes any warranty of any kind, express or implied, regarding the timeliness, sequence, accuracy, or completeness of any Platform Content. All pricing information provided on the Platform is based on a number of factors, may not be accurate, and is not intended to reflect an active market, or the ability for any individual to transact at such prices. Notice does not independently verify any pricing information and assumes no responsibility for its accuracy. Pricing information displayed does not represent a quote or any other offer to buy or sell at any given price or quantity.
Airtable Stock
Airtable
57.40
-0.07
Anduril Stock
Anduril
51.09
-0.12
Anthropic Stock
Anthropic
58.00
+0.00
Apptronik Stock
Apptronik
13.01
-0.06
Canva Stock
Canva
1,262.52
-6.75
Cerebras Stock
Cerebras
35.79
+0.27
Chime Stock
Chime
27.89
+0.03
Circle Stock
Circle
26.11
+0.00
Cohere Stock
Cohere
139.94
-0.17
Cursor (Anysphere) Stock
Cursor (Anysphere)
230.55
-0.27
DailyPay Stock
DailyPay
21.14
+0.02
Databricks Stock
Databricks
108.80
-0.13
Deel Stock
Deel
31.75
-0.01
Discord Stock
Discord
230.86
-0.27
Epic Games Stock
Epic Games
433.60
+2.54
Figma Stock
Figma
34.86
-0.04
Figure AI Stock
Figure AI
176.79
+2.43
Flock Safety Stock
Flock Safety
15.81
-0.03
Glean Stock
Glean
51.15
-0.06
Groq Stock
Groq
22.08
-0.08